Novartis has received a request from the Department of Justice (DOJ) asking for information about the marketing and pricing of Entresto, the company’s blockbuster combination sacubitril/valsartan drug for heart failure.…
The FDA has teamed up with the National Institutes of Health (NIH), 10 pharmaceutical companies and five nonprofit organizations to launch the Bespoke Gene Therapy Consortium to accelerate development of…
A 10-day course of the inexpensive antidepressant fluvoaxamine cut the risk of COVID-19-related hospitalization by 32 percent in infected patients with comorbidities, a research team in Brazil has found. Source:…
President Biden has dropped all provisions aimed at lowering prescription drug prices from what is the scaled-down $1.75 trillion Build Back Better Act framework negotiated between the White House and…
Houston-based Empower Clinic Services, doing business as Empower Pharmacy, has been sent a lengthy warning letter from the FDA that listed multiple violations — the company’s second warning letter in…
Merck has struck a licensing pact with the Medicines Patent Pool (MPP), a United Nations-supported public health organization serving the developing world, to expand access to its experimental COVID-19 antiviral…
Johnson & Johnson (J&J) has agreed to pay $297 million to Texas by year’s end to settle claims over the company’s alleged role in the state’s opioid epidemic if enough…
Rumors abound that President Biden is soon to nominate former FDA Commissioner Robert Califf as the nominee to replace acting commissioner Janet Woodcock. Source: Drug Industry Daily